CSIC and VioBio Lab have presented the validation and launch of SimVis in a press conference that took place last February 7th at CSIC.
The press conference, was led by Prof. Susana Marcos (Director of VioBio Lab, Co-Inventor of the SimVis technology and 2Eyes Vision co-founder), and María Viñas, Researcher at VioBio Lab, with the attendance of Carlos Dorronsoro, (Co-Inventor of the SimVis technology and 2Eyes Vision co-founder), Álvaro Sánchez-Lozano, Business Developer of 2Eyes Vision, and Enrique Gambra, CTO of 2Eyes Vision
Thanks to SimVis, developed by researchers from the VioBio Lab (CSIC), patients and surgeons have the possibility of seeing the effects of an intraocular multifocal lens realistically before the implantation. This revolutionary concept caught the interest of several media, including Spanish public television (RTVE)
“Visual simulators are an ideal technique to provide patients with a realistic experience of multifocality before the implantation of an intraocular lens. In addition, since the device has been reduced in size and has a more practical design than those currently in the market, the benefits multiply, ” Prof. Marcos concluded during the press conference.
The technology has led to four patents (one of them received the Best Patent of the Year Award from the Madrid+d Foundation) licensed to 2Eyes Vision, a spin-off company from CSIC, funded, among others, by several of the researchers involved in the development of SimVis.
More information about the press conference in the following links: